X4 Pharmaceuticals, Inc.XFORNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-book ratio
Latest
6.66
↑ 407% above average
Average (9y)
1.31
Historical baseline
Range
High:6.66
Low:-0.97
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 6.66 | +128.2% |
| 2023 | 2.92 | +251.9% |
| 2022 | 0.83 | +4.8% |
| 2021 | 0.79 | -55.4% |
| 2020 | 1.77 | +87.8% |
| 2019 | 0.94 | +248.2% |
| 2018 | 0.27 | -48.4% |
| 2017 | 0.53 | +188.9% |
| 2016 | -0.59 | +39.3% |
| 2015 | -0.97 | - |